Available Technologies

No technologies match these criteria.
Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above

Find technologies available for licensing from UCLA.

A Method to Prevent the Myelin Abnormalities Associated with Arginase Deficiency

UCLA researchers in the Department of Surgery have developed a gene therapy to prevent dysmyelination (and other CNS abnormalities) as a result of arginase deficiency.

A Universal Method For Quantifying Proteins, Small Molecules, Lipids, And Electrolytes

UCLA scientists in the Departments of Psychiatry & Biobehavioral Sciences and Human Genetics have developed a novel method for the simultaneous quantification of proteins, small molecules, lipids, and electrolytes.

Exercise In A Pill: Compounds That Reproduce The Effects Of Exercise On Muscle Metabolism And Growth

UCLA researchers in the Department of Neurology have identified and synthesized small molecule analogs that activate skeletal muscle growth, mediated by calcium calmodulin kinase II signaling.

Predicting Cefixime Susceptiblity Using Molecular Genotyping

UCLA researchers in the David Geffen School of Medicine have developed a novel method to detect the susceptibility of Neisseria gonorrhoeae to the antibiotic cefixime.

Financial Model for Informing Value-Based Payment Decisions

Researchers led by David Johnson from the Department of Urologic Oncology and the West Los Angeles Veteran’s Affairs Medical Center have developed an interactive web platform that predicts the financial outcomes for various stakeholders (physicians, hospitals, and payers) of transitioning from fee-for-service to bundled payments for robotic radical prostatectomy.

Treatment for Restoring Ureagenesis in Carbamoyl Phosphate Synthetase 1 Deficiency

UCLA researchers in the Department of Surgery have developed a gene therapy to treat carbamoyl phosphate synthetase 1 deficiency.

Quality Factor Enhancement For Highly-Selective Miniaturized Bandpass Filters

UCLA researchers in the Department of Electrical and Computer Engineering have developed narrowband and high-selective filters with zero-insertion loss.

Treatment For Systemic Mastocytosis In An Infant With Midostaurin

UCLA researchers in the Department of Pediatrics have developed a novel treatment to Systemic mastocytosis (SM) with the tyrosine-kinase inhibitor Midostaurin.